Skip to Content

Pfizer STN 37.5 mg (Sutent 37.5 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 37.5 mg is Yellow, Capsule-shape and has been identified as Sutent 37.5 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 37.5 mg

Sutent 37.5 mg Pfizer STN 37.5 mg

Sutent

Generic Name:
sunitinib
Imprint:
Pfizer STN 37.5 mg
Strength:
37.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00069-0830

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide